Kevin Fernando, MBChB, MSc

Opinion

Thrombocytosis and Cancer Risk: Management in Primary Care

Author:: Kevin Fernando, MBChB, MSc

Publish date: November 18, 2024

Importantly, thrombocytosis is a common incidental finding in around 2% of those over 40 years of age attending primary care.

News

Diabetic Kidney Disease Therapies Keep on FLOWing

Author:: Kevin Fernando, MBChB, MSc

Publish date: September 30, 2024

The FLOW study has elevated semaglutide to a new pillar of care for the management of diabetic kidney disease.

Opinion

Once-Weekly Insulin: A Game-Changer for Primary Care

Author:: Kevin Fernando, MBChB, MSc

Publish date: September 26, 2024

“Game-changer” is an overused term, but from the perspective of primary care, it applies to once-weekly insulin.

Opinion

Debate: Is lasting remission of type 2 diabetes feasible in the real-world setting?

Author:: Kevin Fernando, MBChB, MSc

Publish date: October 18, 2023

Dr. Taylor suggested that we not label these individuals who have lost significant weight as having prediabetes. Instead “postdiabetes” should be p...

Opinion

Beyond A1c: Implementing the new ESC 2023 guidelines

Author:: Kevin Fernando, MBChB, MSc

Publish date: September 21, 2023

Controversially, the updated ESC guidance suggests the use of metformin only in patients with type 2 diabetes and atherosclerotic cardiovascul...

Opinion

Oral GLP-1 agonists could be game changers for obesity

Author:: Kevin Fernando, MBChB, MSc

Publish date: July 6, 2023

I hope that future developments bring the class to an even wider demographic and perhaps reduce some of the global inequities in managing type 2 di...

Opinion

Tirzepatide: Therapeutic titan or costly cure?

Author:: Kevin Fernando, MBChB, MSc

Publish date: June 29, 2023

Positioning tirzepatide as the first injectable of choice after oral treatment escalation with metformin and an SGLT2 inhibitor may remain an aspir...